SIGNATUREFD, LLC - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$6,000
+200.0%
1,119
+404.1%
0.00%
Q4 2021$2,000
-50.0%
2220.0%0.00%
Q3 2021$4,000
-20.0%
2220.0%0.00%
Q2 2021$5,000
-16.7%
2220.0%0.00%
Q1 2021$6,000
+200.0%
2220.0%0.00%
Q4 2020$2,000222
+98.2%
0.00%
Q1 2020$0
-100.0%
1120.0%0.00%
Q4 2019$1,0001120.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Abbot Financial Management, Inc. 1,411,775$25,243,00011.48%
Flagship Pioneering Inc. 38,506,526$688,497,0007.21%
Artal Group S.A. 4,155,625$74,303,0001.66%
HARBOURVEST PARTNERS LLC 986,878$17,645,0001.66%
Nan Fung Group Holdings Ltd 56,768$1,015,0000.32%
Lombard Odier Asset Management (Switzerland) SA 245,013$4,381,0000.27%
Bellwether Advisors, LLC 29,383$525,0000.18%
PDT Partners, LLC 65,991$1,180,0000.08%
Virtus ETF Advisers LLC 7,478$134,0000.06%
HITE Hedge Asset Management LLC 24,911$445,0000.06%
View complete list of RUBIUS THERAPEUTICS INC shareholders